Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 488 participants.
Also called NCT07357987
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 488 participants
- Registry
-
NCT07357987
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07357987. Randomized; single masking; primary purpose treatment. Start 2026-01-22 (actual); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
- Acronym
- ANGEL-MeVO-TNK
- Condition
- Ischemic Stroke
- Condition
- Medium Vessel Occlusion
- Condition
- Tenecteplase
- Condition
- Endovascular Treatment
- Intervention (Procedure)
- Intra-arterial Tenecteplase
- Intervention (Drug)
- standard medical management
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct07357987- Content hash
dae3f0d7a0bc5b91707088f59ee9e3cca7c9d02d7ab3580f2e785112c86eec25